Key result
Autograft valve/root reoperation after Ross procedure carried no hospital mortality, with a 74% freedom from any autograft valve/root reoperation at 15 years.
Why the study?
What are the risks and outcomes of autograft valve/root repair at reoperation in patients with Ross procedure failure?
Population
132 consecutive late survivors of the Ross procedure
Design
Cohort
Follow-up
average 10.8 ± 14.7 years (range 0.4-17)
Authors
Loading...
Reoperations after Ross appear low-risk with durable outcomes; extends single-center data but requires multicenter confirmation before practice change.
Cohort (n=132)
What are the risks and outcomes of autograft valve/root repair at reoperation in patients with Ross procedure failure?
Autograft reoperation after Ross procedure carries negligible hospital risk, and pulmonary valve sparing or repair is feasible in half of patients, with concomitant root remodeling and absence of preoperative severe valve dysfunction predicting successful repair.
Luciani et al. (2012) conducted a cohort in Ross procedure failure (n=132). Autograft valve/root repair or replacement was evaluated on Freedom from any autograft valve/root reoperation at 15 years. Autograft valve/root reoperation after Ross procedure carried no hospital mortality, with a 74% freedom from any autograft valve/root reoperation at 15 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: